Skip to main content

The next mega merger could be a $60 billion drug deal

Shares in drug company Shire surged in London as Japan's Takeda and Allergan consider bidding.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.